Therapy of herpes zoster infectionsHIRSCH, M. S.European journal of cancer & clinical oncology. 1984, Vol 20, Num 7, pp 871-872, issn 0277-5379Article

AzidothymidineHIRSCH, M. S.The Journal of infectious diseases. 1988, Vol 157, Num 3, pp 427-431, issn 0022-1899Article

Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesisLEVANON, K; NG, V; DRAPKIN, R et al.Oncogene (Basingstoke). 2010, Vol 29, Num 8, pp 1103-1113, issn 0950-9232, 11 p.Article

Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTESRUSCONI, S; MERRILL, D. P; SETA-CATAMANCIO, S. L et al.AIDS (London). 1999, Vol 13, Num 9, pp 1144-1145, issn 0269-9370Article

Establishment of a whole-chick sternum model that recapitulates normal cartilage developmentHIRSCH, M. S; SVOBODA, K. K. H.BioTechniques. 1998, Vol 24, Num 4, pp 632-636, issn 0736-6205Article

The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudineJACOBSON, M. A; DE GRUTTOLA, V; SOEIRO, R et al.AIDS (London). 1995, Vol 9, Num 7, pp 727-734, issn 0269-9370Article

Potential clinical implications of interlaboratory variability in CD4⁺ T lymphocyte counts of patients infected with human immunodeficiency virusSAX, P. E; BOSWELL, S. L; WHITE-GUTHRO, M et al.Clinical infectious diseases. 1995, Vol 21, Num 5, pp 1121-1125, issn 1058-4838Article

A unified scale of solvent polarities for specific and non-speficic interactionsDRAGO, R. S; HIRSCH, M. S; FERRIS, D. C et al.Perkin transactions. 2. 1994, Num 2, pp 219-230, issn 0300-9580Article

Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptaseDA ZHANG; CALIENDO, A. M; ERON, J. J et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 2, pp 282-287, issn 0066-4804Article

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyYUNG-KANG CHOW; HIRSCH, M. S; MERRILL, D. P et al.Nature (London). 1993, Vol 361, Num 6413, pp 650-654, issn 0028-0836Article

Human immunodeficiency virus type 1 (HIV-1) inhibitory interactions between protease inhibitor Ro 31-8959 and zidovudine, 2',3'-dideoxycytidine, or recombinant interferon-αA zidovudine-sensitive or -resistance HIV-1 in vitroJOHNSON, V. A; MERRILL, D. P; TING-CHAO CHOU et al.The Journal of infectious diseases. 1992, Vol 166, Num 5, pp 1143-1146, issn 0022-1899Article

Seroprevalence of human T cell leukemia viruses in selected populations of homosexual menMEYER, R. D; MOUDGIL, T; DETELS, R et al.The Journal of infectious diseases. 1990, Vol 162, Num 6, pp 1370-1372, issn 0022-1899Article

Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virusBLUMBERG, R. S; PARADIS, T; HARTSHORN, K. L et al.The Journal of infectious diseases. 1987, Vol 156, Num 6, pp 878-884, issn 0022-1899Article

Effects of human immunodeficiency virus (HIV) on the cytotoxic response to Epstein Barr virus (HIV) on the cytotoxic response to Epstein Barr Virus (EBV) transformed B lymphocytesBLUMBERG, R. S; PARADIS, T. J; CRAWFORD, D et al.AIDS research and human retroviruses. 1987, Vol 3, Num 3, pp 303-315, issn 0889-2229Article

Infection of the retina by human immunodeficiency virus type IPOMERANTZ, R. J; KURITZKES, D. R; DE LA MONTE, S. M et al.The New England journal of medicine. 1987, Vol 317, Num 26, pp 1643-1647, issn 0028-4793Article

Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cellsSANDSTROM, E. G; ANDREWS, C; SCHOOLEY, R. T et al.Clinical immunology and immunopathology (Print). 1986, Vol 40, Num 2, pp 253-258, issn 0090-1229Article

Infection of human endothelial cells by human T-lymphotropic virus type IHO, D. D; ROTA, T. R; HIRSCH, M. S et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 23, pp 7588-7590, issn 0273-1134Article

Drug therapy: Treatment of herpesvirus injections (First of two parts)HIRSCH, M. S; SCHOOLEY, R. T.The New England journal of medicine. 1983, Vol 309, Num 16, pp 963-970, issn 0028-4793Article

Pharmacokinetics of human and recombinant leukocyte interferon in patients with chronic renal failure who are undergoing hemodialysisHIRSCH, M. S; TOLKOFF-RUBIN, N. E; KELLY, A. P et al.The Journal of infectious diseases. 1983, Vol 148, Num 2, issn 0022-1899, 335Article

ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tractHIRSCH, M. S; DAL CIN, P; FLETCHER, C. D. M et al.Histopathology. 2006, Vol 48, Num 5, pp 569-578, issn 0309-0167, 10 p.Article

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDSHENRY, K; ERICE, A; MARTINEZ, A et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1998, Vol 19, Num 4, pp 339-349, issn 1077-9450Article

Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitroMERRILL, D. P; MANION, D. J; CHOU, T.-C et al.The Journal of infectious diseases. 1997, Vol 176, Num 1, pp 265-268, issn 0022-1899Article

Principles of clinical pharmacology in postexposure prophylaxis. DiscussionFLEXNER, C. W; GERBERDING, J. L; HIRSCH, M. S et al.The American journal of medicine. 1997, Vol 102, Num 5B, pp 32-38, issn 0002-9343Article

Combination chemotherapy for human immunodeficiency virus-1. DiscussionMANION, D. J; HIRSCH, M. S; BARTLETT, J. G et al.The American journal of medicine. 1997, Vol 102, Num 5B, pp 76-80, issn 0002-9343Article

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeterKATZENSTEIN, D. A; HAMMER, S. M; MERIGAN, T. C et al.The New England journal of medicine. 1996, Vol 335, Num 15, pp 1091-1098, issn 0028-4793Article